Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
10/19/2000 | CA2370489A1 49 human secreted proteins |
10/19/2000 | CA2370189A1 48 human secreted proteins |
10/19/2000 | CA2370131A1 62 human secreted proteins |
10/19/2000 | CA2370112A1 Uncoupling proteins |
10/19/2000 | CA2370039A1 Apoptosis-associated gene |
10/19/2000 | CA2370000A1 Antiproliferative activity of g-righ oligonucleotides and method of using same to bind to nucleolin |
10/19/2000 | CA2369976A1 The novel antisense-oligos with better stability and antisense effect |
10/19/2000 | CA2369822A1 Novel human voltage-gated potassium channel |
10/19/2000 | CA2369817A1 Production of attenuated negative stranded rna virus vaccines from cloned nucleotide sequences |
10/19/2000 | CA2369578A1 Compounds and methods for therapy and diagnosis of lung cancer |
10/19/2000 | CA2369454A1 Uses of mammalian ox2 protein and related reagents |
10/19/2000 | CA2369413A1 Transmembrane protein expressed in prostate and other cancers |
10/19/2000 | CA2369384A1 Prostate-restricted gene 30p3c8 expressed in prostate cancer |
10/19/2000 | CA2369262A1 Pulmonary administration of dry powder formulations for treating infertility |
10/19/2000 | CA2369200A1 Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences |
10/19/2000 | CA2369156A1 Non-human transgenic animal whose germ cells and somatic cells contain a knockout mutation in dna encoding 4e-bp1 |
10/19/2000 | CA2369148A1 Anchored strand displacement amplification on an electronically addressable microchip |
10/19/2000 | CA2368953A1 Proteins related to gaba metabolism |
10/19/2000 | CA2368903A1 Detection of chromosome copy number changes to distinguish melanocytic nevi from malignant melanoma |
10/19/2000 | CA2368648A1 Estrogen receptors and bone |
10/19/2000 | CA2366643A1 Method for mapping a dna molecule comprising an ad infinitum amplification step |
10/19/2000 | CA2366520A1 Anti-bacterial vaccine compositions |
10/19/2000 | CA2366359A1 Novel essential bacterial genes and their proteins |
10/19/2000 | CA2365996A1 Electronically mediated nucleic acid amplification in nasba |
10/19/2000 | CA2365984A1 Antisense oligonucleotides comprising universal and/or degenerate bases |
10/19/2000 | CA2365980A1 Amplification and sequencing primer pairs and use thereof |
10/19/2000 | CA2365945A1 Products and methods for treating ptp lar related diseases |
10/19/2000 | CA2365929A1 Novel method for identifying antibacterial compounds |
10/19/2000 | CA2365919A1 Cyclic gmp dependent protein kinase as a chemotherapeutic target for antiprotozoal agents |
10/19/2000 | CA2365918A1 49 human secreted proteins |
10/19/2000 | CA2365917A1 Bone morphogenic proteins |
10/19/2000 | CA2365916A1 Novel lipoxygenase proteins and polynucleotides encoding the same |
10/19/2000 | CA2365915A1 Recombinant toxin a/toxin b vaccine against clostridium difficile |
10/19/2000 | CA2365914A1 Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines |
10/19/2000 | CA2365913A1 Tumor necrosis factor receptor homologs and nucleic acids encoding the same |
10/19/2000 | CA2365912A1 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
10/19/2000 | CA2365911A1 Recombinant and mutant adenoviruses derived of bovine adenovirus type 1 |
10/19/2000 | CA2365910A1 Human proteins and polynucleotides encoding them |
10/19/2000 | CA2365908A1 Reagents and methods for identifying and modulating expression of genes regulated by p21 |
10/19/2000 | CA2365906A1 Carotene hydroxylase and method for producing xanthophyll derivatives |
10/19/2000 | CA2365905A1 48 human secreted proteins |
10/19/2000 | CA2365901A1 Tissue-specific and pathogen-specific toxic agents and ribozymes |
10/19/2000 | CA2365623A1 Tyrosine kinase substrate (tks) proteins |
10/19/2000 | CA2365522A1 48 human secreted proteins |
10/19/2000 | CA2364690A1 Novel transduction molecules and methods for using same |
10/19/2000 | CA2364577A1 Regulation of repressor genes using nucleic acid molecules |
10/19/2000 | CA2364572A1 Pcr-based cloning method |
10/19/2000 | CA2364565A1 Glucose dehydrogenases |
10/19/2000 | CA2364541A1 Genes associated with diseases of the kidney |
10/19/2000 | CA2364536A1 Fragments of virus protein 2 or 3 of polyoma virus, as vehicules for active substances |
10/19/2000 | CA2360318A1 A second mammalian tankyrase |
10/18/2000 | EP1045037A1 Plant cell identification system |
10/18/2000 | EP1045036A2 Methods and devices for performing analysis of a nucleic acid sample |
10/18/2000 | EP1045034A2 Amplification and detection of shiga-like toxin II producing organisms |
10/18/2000 | EP1045033A2 Amplification and detection of shiga-like toxin I producing organisms |
10/18/2000 | EP1045032A2 Amplification and detection of salmonella spp |
10/18/2000 | EP1045031A2 Amplification and detection of Yersinia enterocolitica |
10/18/2000 | EP1045030A2 Amplification and detection of campylobacter jejuni and campylobacter coli |
10/18/2000 | EP1045028A1 Deoxyribonucleases |
10/18/2000 | EP1045027A1 Novel gene having reverse transcriptase motif |
10/18/2000 | EP1045026A1 A transgenic coagulation factor XIII defective animal and its use for testing wound healing and bleeding |
10/18/2000 | EP1044987A2 Gapped 2'-modified oligonucleotides |
10/18/2000 | EP1044986A2 Amplification and detection of shigella spp. and enteroinvasive strains of escherichia coli |
10/18/2000 | EP1044984A2 Kit for recovering RNA |
10/18/2000 | EP1044605A1 Gene mutant animals |
10/18/2000 | EP1044417A1 Methods and apparatus for performing sequence homology detection |
10/18/2000 | EP1044375A1 Method comprising capture molecule fixed on disc surface |
10/18/2000 | EP1044283A1 Fluorometric method for monitoring and detecting nucleic acid amplification |
10/18/2000 | EP1044280A1 SELECTIVE KILLING AND DIAGNOSIS OF p53?+ NEOPLASTIC CELLS |
10/18/2000 | EP1044279A1 Plants with modified growth |
10/18/2000 | EP1044278A1 Biosynthesis of medium chain length polyhydroxyalkanoates |
10/18/2000 | EP1044277A2 Recombinant, active caspases and uses thereof |
10/18/2000 | EP1044276A2 Proteases from gram positive organisms |
10/18/2000 | EP1044275A1 Mammalian matrix-type metalloprotease |
10/18/2000 | EP1044274A2 Adenoviral vectors with modified capsid proteins |
10/18/2000 | EP1044273A2 COMPOSITIONS DERIVED FROM $i(MYCOBACTERIUM VACCAE) AND METHODS FOR THEIR USE |
10/18/2000 | EP1044272A2 Method for controlling the division and/or elongation of eukariotic cells |
10/18/2000 | EP1044271A1 Il-1 delta dna and polypeptides |
10/18/2000 | EP1044270A2 Apoptosis inducing molecule ii |
10/18/2000 | EP1044269A1 Human vps35/mem3-related protein |
10/18/2000 | EP1044268A1 Novel sequence variants of the human beta2-adrenergic receptor gene and use thereof |
10/18/2000 | EP1044267A2 Novel nucleic acid and polypeptide with homology to the tnf-receptors |
10/18/2000 | EP1044266A2 Human signal peptide-containing proteins |
10/18/2000 | EP1044265A1 Dna encoding a gaba br2 polypeptide and uses thereof |
10/18/2000 | EP1044264A2 Branched chain amino acid biosynthetic enzymes |
10/18/2000 | EP1044263A2 CELLS EXPRESSING ANTI-Fc RECEPTOR BINDING COMPONENTS |
10/18/2000 | EP1044262A1 Sex-specific insemination of mammals with low number of sperm cells |
10/18/2000 | EP1044220A1 Secreted proteins and polynucleotides encoding them |
10/18/2000 | EP1044219A1 DNA MOLECULES ENCODING HUMAN NUCLEAR RECEPTOR PROTEIN, nNR5 |
10/18/2000 | EP1044218A1 Nucleic acids encoding transferrin receptor-like proteins and products related thereto |
10/18/2000 | EP1044217A2 Sag: sensitive to apoptosis gene |
10/18/2000 | EP1044216A1 DNA MOLECULES ENCODING HUMAN NUCLEAR RECEPTOR PROTEINS, nNR7 AND nNR7-1 |
10/18/2000 | EP1044212A1 Human fk506 binding proteins |
10/18/2000 | EP1044211A1 36 human secreted proteins |
10/18/2000 | EP1044210A1 Human dendriac and brainiac-3 |
10/18/2000 | EP1044194A1 Receptor with an affinity for compounds of the oxazoline class |
10/18/2000 | EP1044014A1 Agent for treating allergic or hypersensitivity condition |
10/18/2000 | EP0876385B1 Topiramate immunoassay, as well as analogs and antibodies |
10/18/2000 | EP0797778B1 A method for preparing non-proteinaceous strongly negatively charged macrobiomolecules, which are linked to plastic |
10/18/2000 | EP0577666B1 Polypeptides from mycobacterium paratuberculosis |